These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27590006)

  • 21. CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways.
    Nakamura K; Terai Y; Tanabe A; Ono YJ; Hayashi M; Maeda K; Fujiwara S; Ashihara K; Nakamura M; Tanaka Y; Tanaka T; Tsunetoh S; Sasaki H; Ohmichi M
    Oncol Rep; 2017 Jun; 37(6):3189-3200. PubMed ID: 28440503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of CD44 variant 9 expression as a prognostic indicator in bladder cancer.
    Kobayashi K; Matsumoto H; Matsuyama H; Fujii N; Inoue R; Yamamoto Y; Nagao K
    Oncol Rep; 2016 Nov; 36(5):2852-2860. PubMed ID: 27599396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epithelial-mesenchymal transition markers in malignant ovarian germ cell tumors.
    Solheim O; Førsund M; Tropé CG; Kraggerud SM; Nesland JM; Davidson B
    APMIS; 2017 Sep; 125(9):781-786. PubMed ID: 28585395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer.
    Sillanpää S; Anttila M; Voutilainen K; Ropponen K; Turpeenniemi-Hujanen T; Puistola U; Tammi R; Tammi M; Sironen R; Saarikoski S; Kosma VM
    Gynecol Oncol; 2007 Feb; 104(2):296-303. PubMed ID: 17034838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.
    Tjhay F; Motohara T; Tayama S; Narantuya D; Fujimoto K; Guo J; Sakaguchi I; Honda R; Tashiro H; Katabuchi H
    Cancer Sci; 2015 Oct; 106(10):1421-8. PubMed ID: 26250934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
    Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
    Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
    Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
    Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Helicobacter pylori-induced epithelial-mesenchymal transition, a potential role of gastric cancer initiation and an emergence of stem cells.
    Choi YJ; Kim N; Chang H; Lee HS; Park SM; Park JH; Shin CM; Kim JM; Kim JS; Lee DH; Jung HC
    Carcinogenesis; 2015 May; 36(5):553-63. PubMed ID: 25784376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of transforming growth factor-α, cyclooxygenase-2, matrix metalloproteinase (MMP)-7, MMP-9 and CXCR4 proteins involved in epithelial-mesenchymal transition on overall survival of patients with gastric cancer.
    Fanelli MF; Chinen LT; Begnami MD; Costa WL; Fregnami JH; Soares FA; Montagnini AL
    Histopathology; 2012 Aug; 61(2):153-61. PubMed ID: 22582975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions.
    Davidson B; Holth A; Hellesylt E; Tan TZ; Huang RY; Tropé C; Nesland JM; Thiery JP
    Hum Pathol; 2015 Jan; 46(1):1-8. PubMed ID: 25455994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas.
    Mikami S; Mizuno R; Kosaka T; Saya H; Oya M; Okada Y
    Int J Cancer; 2015 Apr; 136(7):1504-14. PubMed ID: 25123505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
    Gao ZH; Lu C; Wang ZN; Song YX; Zhu JL; Gao P; Sun JX; Chen XW; Wang MX; Dong YL; Xu HM
    Histopathology; 2014 Oct; 65(4):527-38. PubMed ID: 24738665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Akt2/ZEB2 may be a biomarker for exfoliant cells in ascitic fluid in advanced grades of serous ovarian carcinoma.
    Liu C; Yang F
    Tumour Biol; 2015 Sep; 36(9):7213-9. PubMed ID: 25894377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role and prognostic significance of the epithelial-mesenchymal transition factor ZEB2 in ovarian cancer.
    Prislei S; Martinelli E; Zannoni GF; Petrillo M; Filippetti F; Mariani M; Mozzetti S; Raspaglio G; Scambia G; Ferlini C
    Oncotarget; 2015 Aug; 6(22):18966-79. PubMed ID: 26136338
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma.
    Hu Y; He MY; Zhu LF; Yang CC; Zhou ML; Wang Q; Zhang W; Zheng YY; Wang DM; Xu ZQ; Wu YN; Liu LK
    J Exp Clin Cancer Res; 2016 Jan; 35():12. PubMed ID: 26769084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited independent prognostic value of MMP-14 and MMP-2 expression in ovarian cancer.
    Vos MC; van der Wurff AA; Bulten J; Kruitwagen R; Feijen H; van Kuppevelt TH; Hendriks T; Massuger LF
    Diagn Pathol; 2016 Apr; 11():34. PubMed ID: 27038607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression profile of epithelial-mesenchymal transition markers in non-muscle-invasive urothelial carcinoma of the bladder: correlation with intravesical recurrence following transurethral resection.
    Liu B; Miyake H; Nishikawa M; Fujisawa M
    Urol Oncol; 2015 Mar; 33(3):110.e11-8. PubMed ID: 25262382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Outcome of Mesenchymal Transition Biomarkers in Correlation with EGFR Expression in Epithelial Ovarian Carcinoma Patients.
    Kamal IM; Temerik DF; Yassin EH; Mosad E; A H; Hussien MT
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4213-4225. PubMed ID: 36580004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.
    Sosulski A; Horn H; Zhang L; Coletti C; Vathipadiekal V; Castro CM; Birrer MJ; Nagano O; Saya H; Lage K; Donahoe PK; Pépin D
    PLoS One; 2016; 11(6):e0156595. PubMed ID: 27253518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Over expression of galectin-3 associates with short-term poor prognosis in stage II colon cancer.
    Huang Z; Ai Z; Li N; Xi H; Gao X; Wang F; Tan X; Liu H
    Cancer Biomark; 2016; 17(4):445-455. PubMed ID: 28085015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.